4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Cofoe Medical Technology Co.,Ltd. (1187) operates in the Medical Devices industry and is headquartered in Changsha, China with about 5,081 employees. Its market capitalization is roughly CNY 7 billion. In the fiscal year ended 2025-12-31, 1187 reported CNY 3.4B in revenue and CNY 372M in net income.
Cofoe Medical Technology Co.,Ltd. engages in the research and development, production, sales, and service of home care medical devices in China. The company offers medical and wellness products for various types of diseases treatment, damage therapy, daily health maintenance, and life quality improvement.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | CNY 3.4B | CNY 3.0B | CNY 2.9B | CNY 3.0B | — |
| Gross Profit | CNY 1.8B | CNY 1.5B | CNY 1.2B | CNY 1.2B | — |
| Operating Income (EBIT) | CNY 396M | CNY 362M | CNY 278M | CNY 328M | — |
| Net Income | CNY 372M | CNY 312M | CNY 254M | CNY 302M | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | CNY 1.0B | CNY 990M | — | CNY 758M | CNY 738M | CNY 734M |
| Gross Profit | CNY 558M | CNY 522M | — | CNY 400M | CNY 385M | CNY 392M |
| Operating Income (EBIT) | CNY 144M | CNY 100M | — | CNY 84M | CNY 117M | CNY 65M |
| Net Income | CNY 107M | CNY 111M | — | CNY 76M | CNY 91M | CNY 60M |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Dividends Paid | (CNY 372M) | (CNY 374M) | (CNY 250M) | (CNY 260M) |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|
| Dividends Paid | (CNY 1M) | (CNY 5M) | (CNY 245M) | (CNY 2M) | (CNY 124M) |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | CNY 6.6B | CNY 6.4B | CNY 6.2B | CNY 6.4B | — |
| Total Liabilities | CNY 1.7B | CNY 1.6B | CNY 1.3B | CNY 1.4B | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 1187 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms